Introduction Over the last decade, solid phase synthesis and combinatorial chemistry have undergone major evolution. In the early years, the process of.

Slides:



Advertisements
Similar presentations
Buffer Capacity Lab.
Advertisements

Combinatorial Technology Supervisory Patent Examiner
D9 – Drug Design (HL). D.9.1 Discuss the use of a compound library in drug design  Over the years, molecules of various substances have been isolated.
Ufedo Ruby Awodi and Greg L. Challis
Rob Brown Special Topic – 25/01/112
Asymmetric ketone and imine reductions using ruthenium catalysts Jonathan Hopewell, José E. D. Martins and Martin Wills* 1) M. Wills, D. S. Matharu and.
Drug design.  electronic databases  contain molecules which have been isolated or synthesized and tested by pharmaceutical companies for possible pharmaceutical.
Enzyme Kinetic Zhi Hui.
A Green Approach to Nitrogen Heterocycles: Application to Biologically Active Compounds Name: Josephine Dimbleby Department: Chemistry Supervisor: Andy.
Drug Discovery The use of solid phase combinatorial chemistry and parallel synthesis.
Sept 21, 2006 SMALL MOLECULE INHIBITORS OF ANTHRAX LETHAL FACTOR Phase I SBIR Project Period 7/01/05-6/30/07 P.I. Norton Peet John D. Williams.
A Theory of Biological Pattern Formation Presented by Xia Fan.
Exp 13 Volumetric Analysis: Acid-Base titration
Cyclic Aminal of TsDPEN: Synthesis and Use as Asymmetric Organocatalysts Rina Soni, Silvia Gosiewska, Guy Clarkson, Martin Wills * Department of Chemistry,
 Used extensively in relation with drug discovery  Principle of Combinatorial Chemistry ◦ Generation of Compound Libraries from Molecular Building blocks.
2 Transition metal-free catalytic hydrogenation of ketones Katherine Jolley and Martin Wills Department of Chemistry, The University of Warwick, Coventry,
27.14 The Strategy of Peptide Synthesis
Crazy about biomedicine
Chem 27 - Exam 1 Review Wednesday Feb. 22, 2006 Science Center Hall D K.C. O’Brien Carol Fang Walter Kowtoniuk.
Combinatorial Chemistry and Library Design
Chemistry 20 Chapter 15 Enzymes.
The Effects of Glutamine Concentration on the Development of B16 Melanoma Yi Wang Advisor: Dr. Spilatro Introduction Melanoma, widely referred to as the.
An Introduction to Medicinal Chemistry 3/e COMBINATORIAL CHEMISTRY
ENZYMES. Biological Catalysts Enzymes are complex proteins, usually having either tertiary or quarternary structure, and are responsible for mediating.
RemindersReminders Biosphere Observations – Note: there will be NO tutorial on Friday!
Combinatorial chemistry The basic principles. What is it about? Synthesising a large number of similar compounds in a short period of time. Compounds.
Biotechnology in Medicine Chapter 12.
Combinatorial Chemistry
Daniel Brown. D9.1 Discuss the use of a compound library in drug design. Traditionally, a large collection of related compounds are synthesized individually.
D9 Drug design Compound libraries Combinatorial and parallel chemistry
Drug design.  electronic databases  contain molecules which have been isolated or synthesized and tested by pharmaceutical companies for possible pharmaceutical.
COMBINATORIAL CHEMISTRY AND DYNAMIC COMBINATORIAL CHEMISTRY Sonya Balduzzi, PhD.
ERT106 BIOCHEMISTRY PROTEIN TECHNOLOGY By Pn Syazni Zainul kamal.
A Guide to the Natural World David Krogh © 2011 Pearson Education, Inc. Chapter 6 Lecture Outline Life’s Mainspring: An Introduction to Energy Biology.
16-1 Principles and Applications of Inorganic, Organic, and Biological Chemistry Denniston, Topping, and Caret 4 th ed Chapter 16 Copyright © The McGraw-Hill.
1 © Patrick An Introduction to Medicinal Chemistry 3/e Chapter 14 COMBINATORIAL CHEMISTRY Part 2: Sections 14.5 – 14.6.
Drug Design Geometrical isomerism Chirality
Combinatorial Chemistry Advanced Medicinal Chemistry (Pharm 5219): Section A Ref.: An Introduction to Medicinal Chemistry, 3 rd ed. 2005, G.L.Patrick,
Combinatorial Chemistry. Synthesis of many structures (diversity) combinatorial technology, combinatorial library molecular diversity What is Combinatorial.
Abstract Abstract Introduction Introduction Results Chee Yang, Daniel H. Rose and Dr. Thao Yang  Chemistry  University of Wisconsin-Eau Claire Chee Yang,
A Novel Approach to Resin-based Cysteine Alkylation Bin Yang and Richard DiMarchi Department of Chemistry, Indiana University, Bloomington, Indiana,
1 DNA-Templated Synthesis: Principles of Evolution in Organic Chemistry.
Paul Hagey, Eamonn F. Healy, St. Edward’s University,
SOLID PHASE CHEMISTRY.
DEFINITION The automated synthesis of a large number of compounds in a short time period using a defined reaction route and a large variety of reactantsThe.
Peptides Martina Zlámalová. Peptide Synthesis Methodology is carried out by FMOC chemistry, using PEG-Polystyrene resins peptides are cleaved from the.
Two different therapeutic approaches for treating: A.A DNA virus (e.g. Herpes) B.An RNA virus (e.g. Influenza)
Amino Acids, Peptides, and Proteins. Introduction to Amino Acids  There are about 26 amino acids, many others are also known from a variety of sources.
Chemistry of Life Chapter 2. All Living Things Use Energy Energy in living things is converted from 1 form to another (chemical-physical-thermal etc.)
Progress towards the Synthesis of 1-Benzoxepin; A Model Oxepin Substrate Ian Smith, Ryan Fitzgerald, Holly Guevara, Arthur Greenberg
O In Scheme 1, the first 4 steps have been carried out, resulting in the synthesis of Structure 4. o So far, high percent yields suggest that Scheme 1.
Combinatorial Chemistry
Nehad A. El Sayed, Amal A. H. Eissa, Reem K. Arafa and Ghada F. El Masry* Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University.
Synthetic chemicals and natural products Synthetic chemicals are made by the use of chemically reactive reagents. Natural Products are synthesized from.
Combinatorial chemistry
Teaching Aids Service by KRRC Information Section.
Drug Design Geometrical isomerism Chirality
Chapter 22 The Organic Chemistry of Amino Acids, Peptides, and Proteins Paula Yurkanis Bruice University of California, Santa Barbara.
Molecules derived from Amino Acids
An Introduction to Medicinal Chemistry 3/e COMBINATORIAL CHEMISTRY
Chapter 5. Protein Purification and Characterization Techniques
Isolation of the Desired Product (III)
Chemical synthesis of Peptide
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
Introduction of Combinatorial Chemistry
2nd Lecture Comb Chem. 5th Year Pharmacy
Kinetics analysis of β-fructofuranosidase enzyme
Results and Discussion:
Amino acids, Peptides and Proteins By Prof. Dr. Adel M. Awadallah
A Universal Screening Assay for Glycosynthases: Directed Evolution of Glycosynthase XynB2(E335G) Suggests a General Path to Enhance Activity  Alon Ben-David,
Presentation transcript:

Introduction Over the last decade, solid phase synthesis and combinatorial chemistry have undergone major evolution. In the early years, the process of split and mix revolutionized the concept of library synthesis, however, this strategy is less widely used, due in large measure to the fact that compound mixtures appeared to be problematic in terms of screening, while the alternative approach, single bead screening, suffers from many practical and synthesis problems not the least of these are the vast numbers of screens necessary when screening large split and mix libraries, and compound quantity. Thus to apply split and mix methodology effectively, efficient screening processes on single bead must be developed which allow the direct identification of the active bead and thus the active compound. Where release is required, it would be ideal if the cleavage could take place directly in a biologically compatible environment. I. Linker synthesis 1 For this purpose, a specific “biologically” compatible safety-catch linker has been tailored to release amine based compounds for direct screening assays. The linker was synthesized in solution on a core based on proline and glutamic acid derivatives. Amine derivatives were pre-loaded on the linker before its attachment on Tentagel resin. The release mechanism based on the internal formation of a diketopiperazine was activated by reaction of the resin with TFA. Release was achieved in a phosphate buffer at pH 8 after activation of the safety-catch linker with TFA. Primary, secondary, aromatic amines and amidines led to high purity released material; only benzyl amines led to lower purity. Utilization of a “Biological” Safety-Catch Linker for Direct Screening Assays for Direct Screening Assays David Orain a and Mark Bradley b, * a) Current adress : Novartis Pharma AG, Lichtstrasse 35, WSJ , CH-4056 Basel, Switzerland, b) University of Southampton, Department of chemistry, Highfield, Southampton SO17 1BJ, UK ~ bradley

II. Synthesis of TR inhibitors 2 This new linker was used in the synthesis of known inhibitors of Trypanothione Reductase to demonstrate its potential to be used in a direct screening assay. This enzyme is key to the cell’s defence against oxidative stress, and is also present in the causative agents of the African sleeping sickness, leishmaniasis (skin lesions) and Chaga’s disease which is responsible of thousands of deaths each year on the north American continent. 3 From a spermidine core loaded on the linker, three different inhibitors were synthesised by solid phase peptide synthesis. After activation of the safety-catch linker, cleavage in phosphate buffer afforded relatively pure material.

Kinetics showed that the cleavage rate was dependent on the hydrophilicity of the lateral chain of the amino acids used. More interestingly, multiple releases could be achieved with this linker and so lead to the possibility of direct identification of the active compound without any other encoding techniques required.

III Direct enzymatic screening To determine the ability of this system to allow direct screening, a small library of 9 compounds was synthesized and cleaved individually. The crude solutions of inhibitors were tested directly on the enzymatic system. The inhibition rates were followed by consumption of NADPH at 340 nm or by generation of 2-nitrobenzothiol from the Ellman reagent at 415 nm. A good correlation was obtained between the relative inhibition rates obtained in this study and previous works. 4

% Inhibition recorded at 415 nm% Inhibition recorded at 340 nm

Direct bead screening was then investigated on high-loading Tentagel beads. From Tentagel beads with a loading of 800 pmol/bead, a dendrimer was added to reach a level of loading around 2 nmol/bead. On these high-loading beads, the linker- spermidine scaffold was loaded and then the synthesis of the most active inhibitor from the previous screening was carried out. After activation of safety-catch linker with TFA, the beads were washed carefully before being spatially addressed in wells.

Conclusion A new “biological” compatible safety-catch linker has been synthesized allowing a wide range of amines to be anchored. This linker has then been used in the synthesis of Trypanothione Reductase inhibitors. Direct screening assays with crude cleavage solution were then carried out and the inhibition rates were similar to previous works. On high-loading beads, direct one bead screening was realized and relatively good inhibition was achieved. Other dendrimers are being studied to reach higher bead capacity to allow a more efficient one bead screening library.Acknowledgements We thank the BBSRC (51/BO9512) for funding.References 1 1 Orain, D.; Bradley, M. Mol. Div. 2000, 5(1), Orain, D.; Bradley, M. Tetrahedron Lett. 2001, 42, Schirmer, R. H.; Muller, J. G.; Krauth-Siegel, R. L. Angew. Chem. Int. Ed. Engl. 1995, 34, Smith, H. R.; Bradley, M. J. Comb. Chem. 1999, 1, 326. % Inhibition for a direct bead screening Different buffers were studied and best results were obtained when cleavage was carried out in a sodium tetraborate buffer 100 mM pH 8.0. Inhibition rates were measured at 340 nm and 415 nm, and the first results showed that 35% and 21% of inhibition were obtained on a single bead respectively.